We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDER Issues MAPP on Parenteral Drugs in Plastic Immediate Containers
CDER Issues MAPP on Parenteral Drugs in Plastic Immediate Containers
CDER’s Office of New Drugs issued a new manual of policies and procedures, effective immediately, concerning NDAs for parenteral drugs that will be packaged in plastic immediate containers.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor